Read + Share
Crea F. Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS
patients who proceed to PCI and pretreatment should not be performed in patients
planned for an early invasive strategy. Eur Heart J 2021;42:2973-2985.
PMID: 34110420
|
 |
|
